West Virginia University’s School of Pharmacy will soon become one of the few pharmacy schools in the nation that leads a center of biomedical research excellence. Funded by the National Institutes of Health, these centers support interdisciplinary, thematically related research into preventing, diagnosing and treating health problems.
Four factors increase the odds that a patient will wind up on chronic opioid therapy, suggests research conducted by a team of researchers led by Nilanjana Dwibedi, assistant professor in the West Virginia University School of Pharmacy.
This class of more than 4,450 is likely a generation prepared for enacting “vital change,” having earned a University record 10 Fulbright Scholarships, two Boren Scholarships, an NSF Graduate Research Fellowship and a Truman Scholarship. Eight students were named to the Order of Augusta, WVU’s most prestigious student honor.
Renowned West Virginia novelist Ann Pancake leads the list of honorary degree recipients when West Virginia University sends more than 4,450 graduates into the world the weekend of May 11-13 as commencement ceremonies take place in three venues for 13 colleges and schools. Of those graduates, 3,009 have earned their undergraduate degrees or certificates, 1,110 their master’s degrees and 360 have earned their doctorates.
The School of Social Work at West Virginia University shot up into the top third in the latest rankings of graduate programs by U.S. News & World Report.
With age comes a higher prevalence of chronic illness, often resulting in the use of multiple prescription medications at a time. With the help of a new award, a West Virginia University researcher is examining the prevalence and hazards of potentially inappropriate medication prescribing among elderly cancer survivors.
West Virginia University’s LaunchLab Network hosted its first Women’s Pitch Competition on Oct. 26 to encourage female students to push the limits of their entrepreneurial ideas, develop products and business models and showcase the results in a tightly-timed presentation to a panel of judges.
Up to 20 percent of people with opioid use disorder may not respond to standard treatment. A new study at West Virginia University seeks to understand why.
Researchers at West Virginia University are hard at work trying to solve the vexing problem of why some people diagnosed with devastating diseases such as leukemia and bone marrow failure do not respond effectively to standard treatments. Dr. Wei Du and a team of researchers at the WVU Cancer Institute and the School of Pharmacy are using an innovative drug to solve the problem.
As West Virginians face the challenges of 21st century health care, scholars at West Virginia University aspire to help students see this reality from a variety of perspectives.